Summary.-The carcinogenic effects of dimethylnitrosamine (DMN) and nitrosomethylurea (NMU) injected subcutaneously at 3 different dose levels in European hamsters were studied. DMN induced malignant haemangioendotheliomata of the liver and kidney, hepatocellular carcinomata and, in one animal, a cholangiocellular carcinoma. The effect of NMU was localized at the site of administration and resulted in subcutaneous fibrosarcomata, carcinosarcomata or epidermal carcinomata.
IN ANIMAL experiments, the nitroso compounds dimethylnitrosamine (DMN) and nitrosomethylurea (NMU), both thought to react through the same metabolic pathway (Magee, 1973) , show strong carcinogenic effects. Molecular alterations of certain cell constituents, partioularly nucleic acids and proteins, are considered to be responsible for these effects. The results obtained may vary among species due to the biological response of the animals to the carcinogenic interactions. This study involves the investigation of the carcinogenic effects of both DMN and NMU in the European hamster (Cricetus cricetus L.), a new animal model in cancer research.
MATERIALS AND METHODS
Wild European hamsters of unknown age (40 males, average body weight, 255 g and 40 females, average body weight, 185 g) were captured in Niedersachsen, West Germany. Thirty males and 30 females were divided into 6 equal groups, each group receiving weekly subcutaneous injections of either 0 2, 0-1 or 0-05 of the LD50 of DMN or NMU in physiological saline. The LD50 was determined according to the method of Weil (1952 In the control group, 3 males developed spontaneous tumours: 2 papillomata of the forestomach and one adenoma of the adrenal cortex. They were found between the 38th and 45th weeks after beginning the experiment.
Dimethylnitrosamine (DMN)
The results of DMN application are summarized in the Table. There were statistically significant differences in survival rates dependent upon the dosage of the group (P < 0.05). The first tumour, a squamous cell carcinoma in the apical region of the nasal cavity, appeared in a female of the group given 0-2 of the LD50, 13 weeks after initial application, while the earliest neoplasms of the liver appeared after 24 weeks and the earliest kidney tumour after 28 weeks. Both tumours developed in females of the 0*05 of the LD50 dosage group. Histologically, the liver tumours found were of either vascular (10) or hepatocellular (5) origin; one tumour showed a mixed pattern with vascular and hepatocellular parts; in addition, a cholangiocellular carcinoma was found. All neoplasms were malignant, with infiltration of the parenchyma and sometimes of the surrounding organs (peritoneum, pancreas, spleen, intestine). The vascular neoplasms were diagnosed as malignant haemangioendotheliomata or angiosarcomata (Fig. 1) ; three metastasized to the lungs. The hepatocellular carcinomata were characterized by an arrangement of tumour cells found surrounding extensive bleeding parts. Regions with fatty degeneration, necroses of liver cells and proliferation of the bile ducts were encountered regularly in all liver neoplasms.
Kidney tumours were observed more frequently in females than in males. These neoplasms were also classified as malignant haemangioendotheliomata or angiosarcomata of a well defined vascular nature (Fig. 2) ; endothelial cells which were highly pleomorphic with accentuated mitotic activity surrounded small bloodfilled vessels. In 6 animals angiosarcomata of both the liver and the kidney were identified.
Nitrosomethylurea (NM U)
The Table also summarizes the results of NMU treatment. As the dosage decreased, there was a statistically significant increase in survival (P < 0.05). Repeated injections of the carcinogen always produced inflammation at the site of administration, and in most cases a localized tumour developed. The latter was first observed 9 weeks after the initial injection in a male of the 0-2 of the LD50 dosage group. The histology of these tumours showed subcutaneous pleomorphic fibrosarcomata (Fig. 3) (24) , epidermal squamous cell carcinomata (Fig.  4) (7) and carcinosarcomata ( Fig. 5) (Magee, 1973) , but have been shown to produce tumours of different origins and sites. This may be due to the chemical instability of NMU and its tendency to degenerate rapidly at the site of injection, whereas DMN requires the action of an enzyme system for its decomposition.
These properties are exhibited here and also in the Syrian golden hamster (Haas, Kruger and Mohr, 1973) and in rats (Druckrey et al., 1967) .
As in mice (Takayama and Oota, 1963; Toth, Magee and Shubik, 1964) , rats (Druckrey et al., 1967) and Syrian golden hamsters (Haas et al., 1973; Stenback et al., 1973) , DMN given over a long period of time to the European hamster proved to be primarily a carcinogen of the liver, affecting especially the vascular, hepatocellular and in a few cases the cholangiocellular tissues. More-over, this carcinogen appears to show a high affinity for the vascular tissue as this was the most sensitive in the liver and the sole tissue affected in the kidney in these studies. A predominant vascular cytotrophy was also reported for mice (Cardesa et at., 1973) and Syrian golden hamsters (Stenback et at., 1973) . Renal angiosarcomata were reported in rats treated with DMN (Hard and Butler, 1971) , but the vascular nature here could often be ascertained ultrastructurally whereas in the European hamsters these tumours seemed to be of a well-defined vascular structure, even when seen only with the light microscope. The effects of NMU were localized. It should be noted that although the carcinogen was injected subcutaneously, epidermal carcinomata evolved, which is in contrast to the results reported for the Syrian golden hamster (Haas et al., 1973) . Possibly, these carcinomata, as well as the epidermal parts of the carcinosarcomata, are the products of a reaction following initial inflammation, regeneration, disturbed regeneration and finally transformation.
